The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 22, 2020
Filed:
Aug. 01, 2019
Applicant:
Cidara Therapeutics, Inc., San Diego, CA (US);
Inventors:
Kenneth Bartizal, La Jolla, CA (US);
Paul Daruwala, Del Mar, CA (US);
Voon Ong, San Diego, CA (US);
Maureen Roden, Severna Park, MD (US);
Taylor Sandison, Encinitas, CA (US);
Dirk Thye, San Diego, CA (US);
Assignee:
Cidara Therapeutics, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/12 (2006.01); A61K 9/00 (2006.01); A61P 31/10 (2006.01); A61K 47/06 (2006.01); A61K 45/06 (2006.01); C07K 7/50 (2006.01);
U.S. Cl.
CPC ...
A61K 38/12 (2013.01); A61K 9/007 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/0073 (2013.01); A61K 38/005 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61P 31/10 (2018.01); C07K 7/50 (2013.01);
Abstract
The disclosure relates to methods of prophylactic and therapeutic treatments of ainfection (i.e., an infection caused by) in a subject by administering to the subject a compound of any of formulas (I)-(III) (e.g., a salt of Compound 1, or a neutral form thereof). The disclosure also relates to methods of inhibiting the replication of aspp. The methods of the disclosure can be useful in immunocompromised subjects.